FDA: Facebook Link On Novartis AG Drug Website Is Misleading

Published: Aug 06, 2010

Wall Street Journal -- The U.S. Food and Drug Administration said Novartis AG's (NVS, NOVN.VX) use of a Facebook tool on the website for cancer drug Tasigna violated regulations by presenting misleading information about the drug.

Back to news